Respiratory syncytial virus (RSV) causes respiratory ailments like pneumonia and bronchiolitis, mainly affecting children under five and the elderly above 65. Study: Preliminary data on messenger RNA ...

Report Ocean’s comprehensive analysis delves into the Respiratory Syncytial Virus (RSV) landscape, encompassing historical data, forecasted epidemiology, and market trends globally. The report ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to ...

Although RSV is a frequent cause of acute respiratory infections (ARIs), an estimation of its incidence has proven challenging due to a lack of routine testing, overlapping clinical presentations with ...

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract disease ...

WASHINGTON, DC - JULY 21: COVID-19 Response Coordinator Ashish Jha speaks to reporters during a press briefing at the White House July 21, 2022 in Washington, DC. (Photo by Drew Angerer/Getty Images) ...

Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED) visits ...

In a recent study published in JAMA Network Open, researchers assessed the occurrence of respiratory syncytial virus (RSV) infection before and at the time of the coronavirus disease 2019 (COVID-19) ...

Respiratory syncytial virus (RSV) is a common virus that affects the throat, nose, and lungs. Symptoms include a runny nose, congestion, sneezing, wheezing, cough, and fever, and these are often mild ...

Some hospitals are filling up as respiratory infections hits hard and early. It happening just as flu season starts up and another possible COVID-19 wave approaches. Some hospitals in this country are ...